MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcjo.2026.09.012

Медицинская библиотека · Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026

Association of glaucoma diagnosis with sex hormone-related diagnoses and hormone-replacement therapy within a national U.S. database.

Atta Sarah, Eppel Priya, Russell Matthew, Kosuru Sindhu, Asimakis Olivia, Attaran Marjan, Talcott Katherine E, Singh Rishi P, Kaelber David C, Li Ang

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To understand the potential influence of gonadocorticoids on glaucoma susceptibility.

METHODS

We conducted a retrospective cohort study using TriNetX, a multicentre federated health research network, to create cohorts of patients with sex hormone-related diagnoses, including those that lead to increased or decreased estrogen or testosterone states. These were compared with corresponding propensity score-matched control cohorts. Associations between sex hormone states and glaucoma diagnoses/procedures were assessed using standardized differences to identify imbalance. Glaucoma diagnoses were divided into 3 categories: glaucoma suspect, open-angle glaucoma, and narrow-angle glaucoma. Resulting risk ratios, 95% confidence intervals, and P values are reported. A significance level of 0.05 was assumed.

RESULTS

Estrogen-deficient states (including bilateral oophorectomy, primary ovarian failure, and early menopause) showed mixed results. Bilateral oophorectomy (n = 24 798) was associated with a lower risk of glaucoma (P < 0.001), primary ovarian failure (n = 23 853) was not associated with risk of glaucoma, and early menopause (n = 256 043) was associated with an increased risk of glaucoma (P < 0.001). A testosterone-deficient state (male hypogonadism, n = 90 752) was not associated with risk of glaucoma. Increased estrogen (hormone-replacement therapy) (n = 41 144) and long-term estrogen use (n = 39 202) showed decreased risk of glaucoma diagnosis (P < 0.001). Long-term oral contraceptive use (n = 5795) was associated with a lower risk of glaucoma suspect diagnosis (P < 0.001). Increased testosterone (polycystic ovarian syndrome, n = 9181) was not associated with a diagnosis of glaucoma.

CONCLUSIONS

Estrogen- and testosterone-deficient states in this study did not show a consistent pattern with glaucoma risk, whereas estrogen-replacement therapy and long-term estrogen use may confer protective effects.

Для цитирования: Atta Sarah, Eppel Priya, Russell Matthew, Kosuru Sindhu, Asimakis Olivia, Attaran Marjan, Talcott Katherine E, Singh Rishi P, Kaelber David C, Li Ang. Association of glaucoma diagnosis with sex hormone-related diagnoses and hormone-replacement therapy within a national U.S. database.. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2026. DOI: 10.1016/j.jcjo.2026.09.012.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.